# 2025-16850: FDA Reviews Export Paperwork for Medical Devices Abroad

2025-16850, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export of Medical Devices; Foreign Letters of Approval, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-09-03 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-16850
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-16850
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export of Medical Devices; Foreign Letters of Approval
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 42591
- Published: 2025-09-03
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Reviews Export Paperwork for Medical Devices Abroad

## Summary

The FDA is asking for approval to collect info about exporting medical devices and getting foreign approval letters. This affects companies that sell medical devices overseas and helps keep things clear and smooth. No big costs or delays are expected, but folks should keep an eye on the review timeline.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-16850 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/03/2025-16850/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2025-16850 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-03/pdf/2025-16850.pdf)

## Related
- [Previous: 2025-16849, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2025-16849)
- [Next: 2025-16851, Rescissions Proposals Pursuant to the Congressional Budget and Impoundment Cont…](https://policyrisk.com/federal-register/2025-16851)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-16850 (as of 2026-06-08).
